The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. - Related Studies

The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.

This study has been completed.

Study NCT00037219. Last updated on October 17, 2008. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Candidiasis

2	More general conditions related to this trial
		Mycoses

3	Interventions listed in this trial
		Anidulafungin, VER002

4	Additional drug interventions recognized in this trial
		Anidulafungin

5	More general drug interventions related to this trial
		Anti-Infective Agents
		Antibiotics, Antifungal
		Antifungal Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Pfizer
		Vicuron Pharmaceuticals